133 related articles for article (PubMed ID: 37735283)
1. Tumor-microenvironment responsive nano-carrier system for therapy of prostate cancer.
Li L; Li R; Li J; Yao J; Zhang Q; Ji Q; Xu Z
J Mater Sci Mater Med; 2023 Sep; 34(10):46. PubMed ID: 37735283
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer.
Chen Y; Xu Z; Lu T; Luo J; Xue H
Drug Deliv; 2022 Dec; 29(1):2705-2712. PubMed ID: 35980107
[TBL] [Abstract][Full Text] [Related]
4. Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property.
Wang X; Gu Y; Li Q; Xu Y; Shi Y; Wang Z; Xia M; Li J; Wang D
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112164. PubMed ID: 34735859
[TBL] [Abstract][Full Text] [Related]
5. Dual pH/redox-responsive hyperbranched polymeric nanocarriers with TME-trigger size shrinkage and charge reversible ability for amplified chemotherapy of breast cancer.
Badparvar F; Marjani AP; Salehi R; Ramezani F
Sci Rep; 2024 Apr; 14(1):8567. PubMed ID: 38609391
[TBL] [Abstract][Full Text] [Related]
6. Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.
Dong Z; Wang Y; Guo J; Tian C; Pan W; Wang H; Yan J
Drug Des Devel Ther; 2022; 16():2683-2693. PubMed ID: 35983428
[TBL] [Abstract][Full Text] [Related]
7. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.
Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S
Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
[TBL] [Abstract][Full Text] [Related]
9. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
[TBL] [Abstract][Full Text] [Related]
12. Facile synthesis of poly(disulfide)s through one-step oxidation polymerization for redox-responsive drug delivery.
Zhang R; Nie T; Wang L; He D; Kang Y; Zhang C; Wu J
Biomater Sci; 2023 Jun; 11(12):4254-4264. PubMed ID: 37144301
[TBL] [Abstract][Full Text] [Related]
13. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-
Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q
Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335
[TBL] [Abstract][Full Text] [Related]
14. PSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cells.
Jin J; Sui B; Gou J; Liu J; Tang X; Xu H; Zhang Y; Jin X
PLoS One; 2014; 9(11):e112200. PubMed ID: 25386942
[TBL] [Abstract][Full Text] [Related]
15. Binary blended co-delivery nanoparticles with the characteristics of precise pH-responsive acting on tumor microenvironment.
Ye C; Li WJ; Yu HH; Feng QP; Wu X; Zhu YT; Hu MY; Xiang SY; Yu SQ
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111370. PubMed ID: 32919698
[TBL] [Abstract][Full Text] [Related]
16. Reduction-Responsive Docetaxel Prodrug Encapsulated within Human Serum Albumin Nanoparticles for Cancer Therapy.
Zhang Y; Zhang H; Wang J; Liu C; Xing H; Jiang Y; Li X
Mol Pharm; 2023 May; 20(5):2513-2526. PubMed ID: 37071030
[TBL] [Abstract][Full Text] [Related]
17. Tumor pH(e)-triggered charge-reversal and redox-responsive nanoparticles for docetaxel delivery in hepatocellular carcinoma treatment.
Chen F; Zhang J; Wang L; Wang Y; Chen M
Nanoscale; 2015 Oct; 7(38):15763-79. PubMed ID: 26355843
[TBL] [Abstract][Full Text] [Related]
18. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
